Henneman John B III insider trades
Henneman John B III has filed 33 Form 4s with the SEC that we hold, for Aprea Therapeutics, Inc. (APRE) (Director), CIK 1472595 (Director), Anika Therapeutics, Inc. (ANIK) (Director) and Orthofix Medical Inc. (OFIX) (Director), among 6 companies in all. Across all of them we count 3 purchases worth $184.6K and 1 sale worth $858.5K reported on Form 4. In the last 12 months: 2 purchases ($134.6K) and 0 sales ($0). The largest single trade was a sale of 50,000 shares of RCM worth $858.5K, dated 2023-08-08. The first filing on our record is dated 2021-07-01 and the latest 2026-06-23.
Aprea Therapeutics, Inc. (APRE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-03-13 | P, purchase reported on Form 4 | 6,860 | $50.0K | 2024-03-14 |
CIK 1472595
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Anika Therapeutics, Inc. (ANIK)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-05-01 | P, purchase reported on Form 4 | 5,000 | $73.3K | 2026-05-04 |
Orthofix Medical Inc. (OFIX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-05-07 | P, purchase reported on Form 4 | 5,000 | $61.3K | 2026-05-08 |
RCM
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-08 | S, sale reported on Form 4 | 50,000 | $858.5K | 2023-08-09 |
SPNE
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1187572) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms